Equity · Healthcare
ARVN
Arvinas, Inc. · NasdaqGS
$8.12
−1.64% 1D
Finazon · prior-day close
Price · Chart
Chart by TradingView
Crowd sentiment on ARVN · 30d
Bullish
0%
Neutral
100%
Bearish
0%
Across 0 classified mentions in the last 30 days, crowd sentiment for ARVN sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.
ARVN insider trades
Date
Insider
Type
Shares
Value
24 Jun 2026
Bain Linda
Director
AWARD
15,527
—
24 Jun 2026
Cunningham Everett
Director
AWARD
15,527
—
24 Jun 2026
Kennedy Edward Moore Jr.
Director
AWARD
15,527
—
24 Jun 2026
Morrison Briggs
Director
AWARD
15,527
—
24 Jun 2026
Norwalk Leslie V
Director
AWARD
15,527
—
24 Jun 2026
Smaldone Alsup Laurie
Director
AWARD
15,527
—
24 Jun 2026
Saik Andrew
Chief Financial Officer
SELL
5,696
$46K
17 Jun 2026
Cacace Angela M
Chief Scientific Officer
SELL
2,576
$20K
ARVN earnings
Date
Period
EPS
Revenue
31 Mar 2026
Q1 2026
$-0.90
—
31 Dec 2025
FY 2025
$-1.14
$263M
30 Sep 2025
Q3 2025
$-0.48
$42M
30 Jun 2025
Q2 2025
$-0.84
$22M
Reported figures & scheduled dates · SEC EDGAR filings